CellBion Co., Ltd. (KOSDAQ:308430)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,680
-490 (-3.72%)
At close: Jul 24, 2026

CellBion Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,0781,9452,2901,4711,763916.88
Revenue Growth
-19.09%-15.05%55.64%-16.54%92.27%-32.61%
Gross Profit
-59.9683.39963.28313.52203.57-126.94
Operating Income
-9,037-8,245-7,137-5,043-5,303-4,550
Net Income
-8,544-7,574-7,266-3,633-6,382-4,778
Earnings Per Share
-666.35-591.00-716.00-366.00-658.00-543.34
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
20,23622,70830,4597,3705,41210,747
Total Debt
8,3278,4202,054549.272,7782,303
Net Cash (Debt)
11,90914,28828,4056,8212,6348,444
Net Cash Growth
-56.21%-49.70%316.43%158.93%-68.80%258.02%
Net Cash Per Share
928.731114.922798.15687.22271.47960.27

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6,507-5,545-4,777-3,936-4,640-3,491
Capital Expenditures
-2,720-1,472-126.99-304.08-433.86-81.43
Free Cash Flow
-9,227-7,018-4,904-4,240-5,074-3,572
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-2.89%4.29%42.07%21.31%11.55%-13.84%
Operating Margin
-434.87%-423.87%-311.67%-342.79%-300.83%-496.28%
Pretax Margin
-411.18%-389.37%-317.32%-246.92%-362.02%-521.08%
Profit Margin
-411.18%-389.38%-317.32%-246.92%-362.02%-521.08%
FCF Margin
-444.05%-360.79%-214.16%-288.18%-287.84%-389.58%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
78.75155.6965.97---